Sudhir Bhandari

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone

Anil Pareek, Nitin Chandurkar, Nihal Thomas et al. · Current Medical Research and Opinion · 2014 · 101 citations

Medicine, Pharmacology, Pharmacotherapy +16

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Clinical Profile of Covid-19 Infected Patients Admitted in a Tertiary Care Hospital in North India.

Sudhir Bhandari, Abhishek Bhargava, Shrikant Sharma et al. · PubMed · 2020 · 63 citations

Veterinary Medicine, Infectious Diseases, Internal Medicine +17

Logistic regression analysis to predict mortality risk in COVID-19 patients from routine hematologic parameters

Sudhir Bhandari, Ajit Singh Shaktawat, Amit Tak et al. · Ibnosina Journal of Medicine and Biomedical Sciences · 2020 · 57 citations · Full text

Public Health, Health Sciences, Infectious Diseases +15